In this study, JDM patients with eyelid marginal blood vessel dilation were 32% more likely to have elevated vWF:Ag (Table 3), supporting the use of vWF:Ag as a biomarker for vasculitis in JDM. This evidence concerns the gene VWF and juvenile dermatomyositis.